• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

CHOLECYSTOKININ-B RECEPTOR ANTAGONISTS USEFUL FOR DIAGNOSIS AND THERAPY OF HUMAN MALIGNANCIES

Research Project

Project/Area Number 09557085
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Hematology
Research InstitutionKOBE UNIVERSITY

Principal Investigator

MATSUI Toshimitsu  KOBE UNIV MED,LECTURER, 医学部・附属病院, 講師 (10219371)

Co-Investigator(Kenkyū-buntansha) KAJI Hidesuke  KOBE UNIV MED,LECTURER, 医学部, 講師 (90224401)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥6,500,000 (Direct Cost: ¥6,500,000)
Fiscal Year 1998: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 1997: ¥5,100,000 (Direct Cost: ¥5,100,000)
KeywordsCHOLECYSTOKININ / GASTRINR RECEPTOR / LEUKEMIA / RECEPTOR ANTAGONIST / KNOCKOUT MOUSE / CELL GROWTH / LUNG CANCER / COLON CANCER / コレシストニン
Research Abstract

Many peptide hormone and neurotransmitter receptors belonging to the seven membrane-spanning G protein-coupled receptor family have been demonstrated to transmit ligand-dependent mitogenic signals in vitro. The physiological roles of the mitogenic activity through G protein-coupled receptors in vivo had remained to be elucidated. By generating G protein-coupled cholecystokinin (CCK)-B/gastrin receptor deficient-mice by gene targeting, we have clearly demonstrated that the G protein-coupled CCK-B/gastrin receptor is essential for the physiological as well as pathological cell growth in vivo.
CCK-B/gastrin receptor have been shown to be expressed in various lineages of human leukaemia cell lines and be able to promote their growth by an autocrine mechanism. We evaluated the expression of CCK-B/gastrin receptor mRNA in peripheral mononuclear cells of eight patients suffering from de novo acute leukaemia by reverse transcription-polymerase chain reaction. All patients examined (four myeloid … More , three lymphoid and one mixed-lineage) possessed receptor transcript. Among them, five samples also expressed gastrin mRNA.Thus, the autocrine stimulation through the CCK-B/gastrin receptor might be exist in de novo leukaemia cells.
Moreover, the expression of the gastrin and its receptor genes in human colon tumor cells was examined by RT-PCR.Buman colon tumors resected surgically were xenografted to nude mice to eliminate cells other than proliferative carcinoma cells. Unexpectedly, all human colon carcinoma cells (10 samples) grown in nude mice expressed the CCK-B/gastrin receptor transcript. These carcinomas include all sort of differentiation stages. These results suggest that all human colon carcinoma may be derived from the colon mucosa cells expressing CCK-B/gastrin receptors physiologically. Moreover, gastrin mRNA was expressed in the tumor cells as well as in the normal colon mucosa. A gastrin autocrine loop could be present in human colon cancer cells in vivo
The brain CCK-B receptor is identical to the gastrin receptor of the stomach mucosa. However, the affinities for two peptide ligands, CCK-8 and gastrin I, as well as non-peptide ligands vary depend on the animal spieces. Thus, it is important to evaluate the spieces specificity of receptor antagonists. Here, we examined the antagonistic potency of new CCK-B/gastrin receptor antagonists on mouse NIE 3T3 fibroblasts ectopically expressing human CCK-B/gastrin receptors (N-hCCKBR) by determining radioligand binding, intracellular calcium [Ca^<2+>]i and inositol phosphate concentrations. Among several benzodiazepine derivatives, AG-041R had the most potent activities in the competition of [^<125>I]-CCK-8 or [^<125I>]-gastrin I binding, the inhibition of CCK-8- or gastrin I-induced phosphoinositide hydrosis and cytoplasmic free calcium increase. AG-041R is a specific antagonist for human CCK-B/gastrin receptors. Less

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] T.Murayama et al.: "Proliferative reaction of myelogenous leukemia cells with cytokines G-CSF GM-CSF,M-CSF,SCF and TPO" Leukemia Res.22. 557-560 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] K.Kojima et al.: "14_811 abnormality and trisomy ^88 are not common in Japanese T-cell prolymphocytic leukemia" Int.J.Hemato. 68. 291-296 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] K.Miyasaka et al.: "Disruption of cholecystokinin(CCK)-B receptor gene did not modify bile or pancreatic secretion or pancreatic growth A study in CCK-B receptor gene KO mice" Pancreas. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] K.Kojima et al.: "Defective human T-lymphotrophic virus type I provirus in T-cell prolymphocytic leukemia" Br.J.Hematol. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] A.Okamura et al.: "Trisomy 10 in adult pre-B cell leukemia" Am.J.Hematol. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Shimoyama, M., Iwata, N., Ito, M., Murayama, T., Matsuoka, H., Nagata, A., Matsui, T.: "Expression of the cholecystokinin-B/gastrin receptor transcript in de novo acute leukemia cells." Blood. 92 : (Suppl.1). 206b (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Miyasaka, K., Shinozaki, H., Suzuki, S., Sato, Y., Kanai, S., Masuda, M., Jimi, A., Nagata, A., Matsui, T., Noda, T., Kono, A.and Funakoshi, A.: "Disruption of cholecystokinin (CCK)-B receptor gene did not modify bile or pancreatic secretion or pancreatic growth : A study in CCK-B receptor gene knockout mice." Pancreas. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] T.Murayama et al.: "Proliferative reaction of myelogenous leukemia cells with cytokines G-CSF GM-CSF,M-CSF,SCF and TPO" Leukemta Res.22. 557-560 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] K.Kojima et al.: "14_811 abnornality and trisomy 8_8 are not common in Japanese T-cell prohlymphoctic leukemia" Int.J.Hemato. 68. 291-296 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] K.Miyasaka et al.: "Disruption of cholecystokinin (CCK)-B receptor gene did not madify bile or parcreatic secretion or pancreatic grousth : A stuch in CCk-B receptor gene KO mice" Pancreas. (in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] K.Kojima et al.: "Defective human T-lymphotropbic virus type I provirus in T-cell prolymphoctic leukamia" Br.J.Hematol. (in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] A.Okamura et al.: "Trisony 10 in adult pre-B cell leukemia" Am.J.Hematal. (in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] H. Matsuoka et al.: "Expression of a kinase-defective Eph-like receptor expressed in the normal human brain" Biochem. Biophys. Res. Commun.235. 487-492 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] R. Kitazawa et al.: "In situ detection of parathyroid hormeone-related protein in ovraian clear cell carcinoma" Human Pathology. 28. 379-382 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 松井利充他: "消化管ホルモン(XV)" 医学図書出版, 152 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 松井利充他: "ノックアオウトマウス・データブック" 中山書店, 564 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi